Picchi Brothers’ Fellowship to the Asthma and Allergy Service at the Alfred Hospital - 2007
Recipient: Dr. Andrew Gillman
Sponsor: Associate Professor Jo Douglass
Asthma is a common condition affecting approximately 10% of Australian adults. There is no cure, but people can control the disease fairly effectively with current available treatments.
As Australians have a high mortality from asthma compared to international benchmarks (we are ranked no 5), the decision to help with research was fairly obvious to the Board.
As the Alfred Hospital has the only designated Asthma and Allergy service in Victoria, it has direct access to the disease at its worst. In association with the Department of Immunology at Monash University, the shared knowledge base between the units has fostered accelerated information of the immune basis of this allergic disease.
This Fellowship also takes in the study of the effects of Omalizumab with patients with chronic ABPA (Allergic Broncho-Pulmonary Aspergillosis). The results of which may offer promise to provide a new therapeutic option to patients with this severe form of asthma. It will also refine and improve current diagnostic strategies for ABPA.
Project Outcomes: We have seen results as follows:
- Commencement of the study of Ozmalizumab for Chronic Relapsing Allergic Bronchopulmonary Aspergillosis (ABPA)
- The formalisation of the Severe Asthma program
- Participation of Dr. Gillman in Consultative clinics and Education programs
- Lectures to the Lung Health Promotion Centre.
- Regular bedside teaching of Monash Medical Students
- The preparation, submission and acceptance of the manuscript “Why do people with asthma have to fear from food and food additive sensitivity?”.
- Recruiting and supervision of a medical Science student.